Abstract:Background: Long QT syndrome 3 (LQT3) is caused by SCN5A mutations. Late sodium current (late INa) inhibitors are current-specific to treat patients with LQT3, but the mechanisms underlying mexiletine (MEX) -sensitive (N1325S and R1623Q) and -insensitive (M1652R) mutations remains to be elucidated.Methods: LQT3 patients with causative mutations were treated with oral MEX following i.v. lidocaine. Whole-cell patch-clamp techniques and molecular remodeling were used to determine the mechanisms underlying the sensitivity to MEX.Results: Intravenous administration of lidocaine followed by MEX orally in LQT patients with N1325S and R1623Q sodium channel mutation shortened QTc interval, abolished arrhythmias, and completely normalized the ECG. In HEK293 cells, the steady-state inactivation curves of the M1652R channels were rightward shifted by 5.6 mV relative to the WT channel. In contrast, the R1623Q mutation caused a leftward shift of the steady-state inactivation curve by 15.2 mV compared with WT channel, and N1325S mutation did not affect steady-state inactivation (n = 5–13, P < 0.05). The extent of the window current was expanded in all three mutant channels compared with WT. All three mutations increased late INa with the greatest amplitude in the M1652R channel (n = 9–15, P < 0.05). MEX caused a hyperpolarizing shift of the steady-state inactivation and delayed the recovery of all three mutant channels. Furthermore, it suppressed late INa in N1325S and R1623Q to a greater extent compared to that of M1652R mutant channel. Mutations altered the sensitivity of Nav1.5 to MEX through allosteric mechanisms by changing the conformation of Nav1.5 to become more or less favorable for MEX binding. Late INa inhibitors suppressed late INa in N1325S and R1623Q to a greater extent than that in the M1652R mutation (n = 4–7, P < 0.05).Conclusion: The N1325S, R1623Q, and M1652R mutations are associated with a variable augmentation of late INa, which was reversed by MEX. M1652R mutation changes the conformation of Nav1.5 that disrupt the inactivation of channel affecting MEX binding, corresponding to the poor response to MEX. The lidocaine test, molecular modeling, and drugs screening in cells expressing mutant channels are useful for predicting the effectiveness of late INa inhibitors.

Elucidating the Differential Impacts of Equivalent Gating-Charge Mutations in Voltage-Gated Sodium Channels

Mapping structural distribution and gating-property impacts of disease-associated mutations in voltage-gated sodium channels

Comparative structural analysis of human Na<sub>v</sub>1.1 and Na<sub>v</sub>1.5 reveals mutational hotspots for sodium channelopathies

Dissection of the Structure-Function Relationship of Nav Channels

Molecular Dynamics Study of Ion Transport Through an Open Model of Voltage-Gated Sodium Channel

Diverse biophysical mechanisms in voltage-gated sodium channel Nav1.4 variants associated with myotonia

Structural determinants of voltage-gating properties in calcium channels

Unwinding and spiral sliding of S4 and domain rotation of VSD during the electromechanical coupling in Na<sub>v</sub>1.7

Structure-based assessment of disease-related mutations in human voltage-gated sodium channels

A Negatively Charged Residue in the Outer Mouth of Rat Sodium Channel Determines the Gating Kinetics of the Channel.

Characterization of two pathological gating-charge substitutions in Cav1.4 L-type calcium channels

The identification of the key residues E829 and R845 involved in transient receptor potential melastatin 2 channel gating

Comparative Structural Analysis of Human Na V 1.1 and Na V 1.5 Reveals Mutational Hotspots for Sodium Channelopathies

Atomic-Level Investigation of KCNJ2 Mutations Associated with Ventricular Arrhythmic Syndrome Phenotypes

Structure of a eukaryotic voltage-gated sodium channel at near-atomic resolution

Gating Properties of Mutant Sodium Channels and Responses to Sodium Current Inhibitors Predict Mexiletine-Sensitive Mutations of Long QT Syndrome 3

Energetics of discrete selectivity bands and mutation-induced transitions in the calcium-sodium ion channels family

Molecular insights into the gating mechanisms of voltage-gated calcium channel CaV2.3

Unwinding and spiral sliding of S4 and domain rotation of VSD during the electromechanical coupling in Nav1.7

Lysine and the Na+/K+ Selectivity in Mammalian Voltage-Gated Sodium Channels.

The hitchhiker’s guide to the voltage-gated sodium channel galaxy